ChemicalBook--->CAS DataBase List--->2179-37-5

2179-37-5

2179-37-5 Structure

2179-37-5 Structure
IdentificationBack Directory
[Name]

bencyclane
[CAS]

2179-37-5
[Synonyms]

bencyclane
Benzcyclan
Benzcyclane
3-[1-(benzyl)cycloheptoxy]propyl-dimethyl-amine
N,N-dimethyl-3-[1-(phenylmethyl)cycloheptyl]oxypropan-1-amine
N,N-dimethyl-3-[1-(phenylmethyl)cycloheptyl]oxy-propan-1-amine
1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)cycloheptyl]oxy]-
[EINECS(EC#)]

218-547-0
[Molecular Formula]

C19H31NO
[MDL Number]

MFCD00868310
[MOL File]

2179-37-5.mol
[Molecular Weight]

289.46
Chemical PropertiesBack Directory
[Boiling point ]

bp3 146-156°
[density ]

0.97±0.1 g/cm3(Predicted)
[storage temp. ]

Store at -20°C
[solubility ]

Soluble in DMSO
[form ]

Oil
[pka]

pKa 8.94±0.04(40%EtOH t=25.0) (Uncertain)
[color ]

Colorless to light yellow
Safety DataBack Directory
[Symbol(GHS) ]

Exclamation Mark (GHS07)
GHS07
[Signal word ]

Warning
[Hazard statements ]

H302
[Precautionary statements ]

P280-P305+P351+P338
Hazard InformationBack Directory
[Uses]

Benzcyclane (Bencyclane; Benzcyclan) is a platelet aggregation inhibitor and a vasodilator effective in a variety of peripheral circulation disorders.
[Definition]

ChEBI: Bencyclane is a member of benzenes.
[Brand name]

Angiociclan;Angiodel;Bioarterol;Dantrium;Desoblit;Dilangio caposium;Dilapres;Fludilat (r)-dti;Fludilat amp 50 mg;Fludilat drag 100 mg;Fludilat dragee;Fludilat retard;Fludilat tropfen;Flussema;Fluxema;Halidor;Iloramina;Ludilat dti;Novo card-fludilat;Tardilat;Tensilence;Vasodarkey.
[World Health Organization (WHO)]

Bencyclane, a vasodilator, was introduced in 1970 for the treatment of peripheral and cerebral vascular disorders. In 1991, its use was contraindicated by the German authorities in patients at risk of epilepsy following reports of convulsions in patients under treatment. Bencyclane is widely registered and the World Health Organization is not aware of restrictive action having been taken elsewhere.
[in vivo]

Benzcyclane, although capable of aggregating platelets by itself at very high concentrations, shows a striking inhibitory effect, over a wide range of concentrations, both on platelet aggregation induced by ADP, epinephrine or collagen and on platelet adhesiveness to glass or collagen. Clot retraction is also clearly inhibited[1]. Benzcyclane induces use-dependent inhibition of Na channels in muscle, similarly as do class 1 antiarrhytnmic drugs. Inhibition was observed with both normal and cevadine-modified Na channels[2].

[References]

[1] Ponari O, et al. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function. Arzneimittelforschung. 1976;26(8):1532-8. PMID:12770
[2] Nánási PP, et al. Effects of bencyclane on normal and cevadine-modified Na channels in frog skeletal muscle. Gen Physiol Biophys. 1989 Oct;8(5):447-58. PMID:2556322
Spectrum DetailBack Directory
[Spectrum Detail]

bencyclane(2179-37-5)1HNMR
2179-37-5 suppliers list
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Telephone: 010-60605840
Website: http://www.jm-bio.com/
Company Name: Xi'an Qiyue Biotechnology Co., Ltd.  
Telephone: 400-400-6966-012-012 17778955912
Website: http://www.qiyuebio.com/
Company Name: Shaanxi DIDU pharmaceutical and Chemical Co., Ltd  
Telephone: 029-029-81120477 17792793610
Website: http://www.dideu.cn
Company Name: TargetMol Chemicals Inc.  
Telephone: 4008200310 15002144251
Website: https://www.targetmol.cn/
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Telephone: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Telephone: 13370042665 18916960931
Website: www.amole.com.cn/
Tags:2179-37-5 Related Product Information
142-82-5